{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:41:28Z","timestamp":1779313288138,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CB16\/12\/00446"],"award-info":[{"award-number":["CB16\/12\/00446"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00602"],"award-info":[{"award-number":["PI20\/00602"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI21\/00132"],"award-info":[{"award-number":["FI21\/00132"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["1\/29\/2018"],"award-info":[{"award-number":["1\/29\/2018"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.taap.2022.116171","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T11:27:36Z","timestamp":1658489256000},"page":"116171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["SNAI1-expressing fibroblasts and derived-extracellular matrix as mediators of drug resistance in colorectal cancer patients"],"prefix":"10.1016","volume":"450","author":[{"given":"C.","family":"Galindo-Pumari\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Collado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Barqu\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Romio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Larriba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.J.","family":"Mu\u00f1oz de Mier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Carrato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"de la Pinta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2022.116171_bb0005","first-page":"23","article-title":"Effect of modulation of epithelial-mesenchymal transition regulators Snail1 and Snail2 on cancer cell radiosensitivity by targeting of the cell cycle, cell apoptosis and cell migration\/invasion (review)","volume":"17","author":"Assani","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.taap.2022.116171_bb0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35000034","article-title":"The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells","volume":"2","author":"Batlle","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.taap.2022.116171_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8060757","article-title":"Clinical medicine Snail1: a transcriptional factor controlled at multiple levels","volume":"8","author":"Baulida","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.taap.2022.116171_bb0020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.taap.2022.116171_bb0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.taap.2022.116171_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/0284186X.2014.975839","article-title":"Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature","volume":"54","author":"B\u00f6ckelman","year":"2015","journal-title":"Acta Oncol."},{"key":"10.1016\/j.taap.2022.116171_bb0035","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.taap.2022.116171_bb0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-59745-413-1_19","article-title":"Cell adhesion\/spreading assays","volume":"522","author":"Castell\u00f3-Cros","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.taap.2022.116171_bb0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.suronc.2018.05.002","article-title":"High snail expression predicts a poor prognosis in breast invasive ductal carcinoma patients with HER2\/EGFR-positive subtypes","volume":"27","author":"Chang","year":"2018","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.taap.2022.116171_bb0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2022.116171_bb0055","first-page":"482","article-title":"Cancer associated fibroblasts: the dark side of the coin","volume":"1","author":"Cirri","year":"2011","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.taap.2022.116171_bb0060","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis","volume":"11","author":"De Roock","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.taap.2022.116171_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101851","article-title":"Manipulating the tumor microenvironment in tumor organoids induces phenotypic changes and chemoresistance","volume":"23","author":"Dominijanni","year":"2020","journal-title":"IScience"},{"key":"10.1016\/j.taap.2022.116171_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2014.07.009","article-title":"Focal adhesion signaling and therapy resistance in cancer","volume":"31","author":"Eke","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.taap.2022.116171_bb0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2014.07.009","article-title":"Focal adhesion signaling and therapy resistance in cancer","volume":"31","author":"Eke","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.taap.2022.116171_bb0080","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1158\/0008-5472.CAN-13-0344","article-title":"Cetuximab attenuates its cytotoxic and radiosensitizing potential by inducing fibronectin biosynthesis","volume":"73","author":"Eke","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2022.116171_bb0085","series-title":"Highlights of Prescribing Information","author":"Fda, Cder","year":"2022"},{"key":"10.1016\/j.taap.2022.116171_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-0994-2","article-title":"Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance","author":"Fiori","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.taap.2022.116171_bb0095","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1038\/sj.onc.1209519","article-title":"Expression of snail protein in tumor-stroma interface","volume":"25","author":"Franc\u00ed","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2022.116171_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1272-3","article-title":"Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression","volume":"15","author":"Full\u00e1r","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.taap.2022.116171_bb0105","article-title":"Fibroblast-derived 3d matrix system applicable to endothelial tube formation assay","volume":"2019","author":"Galindo-Pumari\u00f1o","year":"2019","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.taap.2022.116171_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13010146","article-title":"Stromal protein-mediated immune regulation in digestive cancers","volume":"13","author":"Gamradt","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.taap.2022.116171_bb0115","doi-asserted-by":"crossref","first-page":"59766","DOI":"10.18632\/oncotarget.11121","article-title":"Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells","volume":"7","author":"Gon\u00e7alves-Ribeiro","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2022.116171_bb0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0093-7754(03)00399-3","article-title":"Oxaliplatin-safety profile: neurotoxicity","volume":"30","author":"Grothey","year":"2003","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.taap.2022.116171_bb0125","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1002\/ijc.28613","article-title":"Protumorigenic effects of snail-expression fibroblasts on colon cancer cells","volume":"134","author":"Herrera","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2022.116171_bb0130","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1773","article-title":"Colon cancer-associated fibroblast establishment and culture growth","volume":"6","author":"Herrera","year":"2016","journal-title":"BIO-PROTOCOL"},{"key":"10.1016\/j.taap.2022.116171_bb0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41389-018-0085-z","article-title":"Endothelial cell activation on 3D-matrices derived from PDGF-BB-stimulated fibroblasts is mediated by Snail1","volume":"7","author":"Herrera","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.taap.2022.116171_bb0140","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.addr.2015.10.007","article-title":"In vitro cancer cell-ECM interactions inform in vivo cancer treatment","volume":"97","author":"Holle","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.taap.2022.116171_bb0145","first-page":"2749","article-title":"Decellularized matrices as in vitro models of extracellular matrix in tumor tissues at different malignant levels: mechanism of 5-fluorouracil resistance in colorectal tumor cells","volume":"2016","author":"Hoshiba","year":"1863","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.taap.2022.116171_bb0150","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/j.bbamcr.2016.08.009","article-title":"Decellularized matrices as in vitro models of extracellular matrix in tumor tissues at different malignant levels: mechanism of 5-fluorouracil resistance in colorectal tumor cells","volume":"1863","author":"Hoshiba","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2022.116171_bb0155","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1126\/science.1176009","article-title":"The extracellular matrix: not just pretty fibrils","volume":"326","author":"Hynes","year":"2009","journal-title":"Science (80-.)"},{"key":"10.1016\/j.taap.2022.116171_bb0160","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.taap.2022.116171_bb0165","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.taap.2022.116171_bb0170","first-page":"1765","article-title":"Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells","volume":"39","author":"Keeratichamroen","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.taap.2022.116171_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12103067","article-title":"Therapy resistance, cancer stem cells and ECM in cancer: the matrix reloaded","volume":"12","author":"Kesh","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.taap.2022.116171_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656364","article-title":"Aspects of the tumor microenvironment involved in immune resistance and drug resistance","volume":"12","author":"Khalaf","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.taap.2022.116171_bb0185","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41575-019-0115-0","article-title":"Cancer-associated fibroblasts in gastrointestinal cancer","volume":"16","author":"Kobayashi","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2022.116171_bb0190","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.semcdb.2019.10.016","article-title":"A centralized communication network: recent insights into the role of the cancer associated fibroblast in the development of drug resistance in tumors","volume":"101","author":"Leask","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.taap.2022.116171_bb0195","article-title":"A peek into cancer-associated fibroblasts: origins, functions and translational impact","volume":"11","author":"LeBleu","year":"2018","journal-title":"DMM Dis. Model. Mech."},{"key":"10.1016\/j.taap.2022.116171_bb0200","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.taap.2022.116171_bb0205","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/bab.1302","article-title":"Role of three-dimensional matrix stiffness in regulating the chemoresistance of hepatocellular carcinoma cells","volume":"62","author":"Liu","year":"2015","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.taap.2022.116171_bb0210","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.2147\/OTT.S231010","article-title":"Matrix stiffness and colorectal cancer","volume":"13","author":"Liu","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.taap.2022.116171_bb0215","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/jcp.24342","article-title":"Snail mediates PDGF-BB-induced invasion of rat bone marrow mesenchymal stem cells in 3D collagen and chick chorioallantoic membrane","volume":"228","author":"Lu","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.taap.2022.116171_bb0220","doi-asserted-by":"crossref","first-page":"64766","DOI":"10.18632\/oncotarget.8649","article-title":"Identification and validation of COX-2 as a co-target for overcoming cetuximab resistance in colorectal cancer cells","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2022.116171_bb0225","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.015222","article-title":"Protein expression signatures for inhibition of epidermal growth factor receptor-mediated signaling","volume":"11","author":"Myers","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.taap.2022.116171_bb0230","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1440-1789.2009.01072.x","article-title":"Snail and Cox-2 expressions are associated with WHO tumor grade and survival rate of patients with gliomas","volume":"30","author":"Myung","year":"2010","journal-title":"Neuropathology"},{"key":"10.1016\/j.taap.2022.116171_bb0235","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1016\/j.biomaterials.2014.03.058","article-title":"Sorafenib resistance and JNK signaling in carcinoma during extracellular matrix stiffening","volume":"35","author":"Nguyen","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.taap.2022.116171_bb0240","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1110-6","article-title":"Collagens and cancer associated fibroblasts in the reactive stroma and its relation to cancer biology","volume":"38","author":"Nissen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.taap.2022.116171_bb0245","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1083\/jcb.200102028","article-title":"Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling","volume":"154","author":"P\u00e1lmer","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.taap.2022.116171_bb0250","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2131","article-title":"Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?","volume":"7","author":"Peinado","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.taap.2022.116171_bb0255","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.yexcr.2010.02.045","article-title":"Hallmarks of cancer: interactions with the tumor stroma","volume":"316","author":"Pietras","year":"2010","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.taap.2022.116171_bb0260","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf5219","article-title":"Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases","volume":"8","author":"Rahbari","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.taap.2022.116171_bb0265","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1083\/jcb.200810113","article-title":"Mesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs","volume":"184","author":"Rowe","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.taap.2022.116171_bb0270","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.taap.2022.116171_bb0275","first-page":"8516","article-title":"In vitro analysis of putative cancer stem cell populations and chemosensitivity in the SW480 and SW620 colon cancer metastasis model","volume":"15","author":"Slater","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.taap.2022.116171_bb0280","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1242\/jcs.078824","article-title":"The p65 subunit of NF-\u03baB and PARP1 assist Snail1 in activating fibronectin transcription","volume":"124","author":"Stanisavljevic","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.taap.2022.116171_bb0285","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1158\/0008-5472.CAN-14-1903","article-title":"Snail1-expressing fibroblasts in the tumor microenvironment display mechanical properties that support metastasis","volume":"75","author":"Stanisavljevic","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2022.116171_bb0290","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ctrv.2015.06.007","article-title":"Rectal and colon cancer: not just a different anatomic site","volume":"41","author":"Tamas","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.taap.2022.116171_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.00022","article-title":"Combined snail and E-cadherin predicts overall survival of cervical carcinoma patients: comparison among various epithelial-mesenchymal transition proteins","volume":"7","author":"Tian","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.taap.2022.116171_bb0300","first-page":"1630","article-title":"Transforming growth factor-alpha production and autoinduction in a colorectal carcinoma cell line (DiFi) with an amplified epidermal growth factor receptor gene","volume":"53","author":"Untawale","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2022.116171_bb0305","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2741\/3613","article-title":"Cancer associated fibroblasts (CAFs) in tumor microenvironment","volume":"15","author":"Xing","year":"2010","journal-title":"Front. Biosci."},{"key":"10.1016\/j.taap.2022.116171_bb0310","article-title":"Role of exosomes in crosstalk between cancer-associated fibroblasts and cancer cells","volume":"9","author":"Yang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.taap.2022.116171_bb0315","doi-asserted-by":"crossref","first-page":"32221","DOI":"10.18632\/oncotarget.8515","article-title":"Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells","volume":"7","author":"You","year":"2016","journal-title":"Oncotarget"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X22003167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X22003167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:05:39Z","timestamp":1778659539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X22003167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":63,"alternative-id":["S0041008X22003167"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2022.116171","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SNAI1-expressing fibroblasts and derived-extracellular matrix as mediators of drug resistance in colorectal cancer patients","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2022.116171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116171"}}